Clinical Trial Update: Quality of Life in Schizophrenic Patients

View source ↗

Summary

AstraZeneca completed a clinical trial evaluating quality of life in patients with schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: AstraZeneca | Conditions: Schizophrenia | Status: COMPLETED